Word

ZYVALKRA

Status

Registered

Status Code

700

Status Date

Tuesday, November 9, 2021

Serial Number

79306253

Registration Number

6549777

Registration Date

Tuesday, November 9, 2021

Mark Type

4000

Filing Date

Friday, January 8, 2021

Published for Opposition

Tuesday, August 24, 2021

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events

Jul 30, 2023

Change Of Name/Address Rec'd From Ib

Mar 12, 2022

Notification Processed By Ib

Feb 23, 2022

Final Disposition Notice Sent To Ib

Feb 22, 2022

Final Disposition Processed

Dec 9, 2021

Grant Of Protection Created, To Be Sent To Ib

Nov 9, 2021

Registered-Principal Register

Aug 24, 2021

Published For Opposition

Aug 22, 2021

Notification Processed By Ib

Aug 4, 2021

Notification Of Possible Opposition Sent To Ib

Aug 4, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Aug 4, 2021

Notice Of Publication

Jul 20, 2021

Approved For Pub - Principal Register

Jul 19, 2021

Assigned To Examiner

Mar 23, 2021

Application Filing Receipt Mailed

Mar 18, 2021

New Application Office Supplied Data Entered

Mar 17, 2021

Limitation From Original Application Entered

Mar 11, 2021

Sn Assigned For Sect 66a Appl From Ib